Growing evidence indicates that Rho GTPases, one of the most important regulators of cytoskeletal protein (Guan et al., 2020), play a crucial role in the abnormal motility of tumor cells (Kim et al., 2022; Qiu et al., 2022; Zhang et al., 2022). Here, DNM2 is linked to neoplasm.